AARTI PHARMALABS
Back to Cashflow Statement
|
AARTI PHARMALABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹332 Cr | ₹216 Cr | ₹250 Cr | ₹-44 Cr | - |
What is the latest Cash Flow from Operating Activities ratio of AARTI PHARMALABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹332 Cr |
| Mar2024 | ₹216 Cr |
| Mar2023 | ₹250 Cr |
| Mar2022 | ₹-44 Cr |
| Mar2021 | - |
How is Cash Flow from Operating Activities of AARTI PHARMALABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹332 Cr | 53.25 | |
| Mar2024 | ₹216 Cr | -13.50 | |
| Mar2023 | ₹250 Cr | Positive | |
| Mar2022 | ₹-44 Cr | 0 | |
| Mar2021 | - | - | |
Compare Cash Flow from Operating Activities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹6,436.5 Cr | 0.5% | 15.1% | -2.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,997.0 Cr | 4.1% | -1.3% | -7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,900.0 Cr | 3% | 7.7% | 7.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,804.0 Cr | 2.1% | 0.1% | 26.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,389.0 Cr | 9.3% | 6.6% | 12% | Stock Analytics | |
| CIPLA | ₹106,397.0 Cr | 6.8% | 7.7% | -15.3% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 0.5% |
15.1% |
-2.3% |
| SENSEX | -1.6% |
3.7% |
-2.7% |
You may also like the below Video Courses